Treloar's College contaminated blood pupils to appeal ruling
Former boarding school pupils who received medical treatments using contaminated blood products in the 1970s and 1980s intend to appeal against a court ruling.Former pupils of the Lord Mayor Treloar School and College in Hampshire, which at the time was a boarding school for children with haemophilia, are seeking legal action against its trust in the High Court.But Judge David Cook declined to make an order to manage the claims together, finding the affected were not a "homogeneous group".The claimants' legal team said they "remain determined to hold the school to account for the wrongs of the past".
At least 72 children died after being given a drug contaminated with HIV and viral hepatitis at the school.At a hearing last month, lawyers for the former pupils and their relatives said the cases should be managed together, while lawyers for the trust said the best way for the former pupils to be compensated will be through the government's Infected Blood Compensation Scheme.Judge Cook said that if multiple claims were brought by 63 potential claimants, their cases could be consolidated."I am, however, far from satisfied that 63 claims will materialise having regard to the imminent approval and implementation of the Infected Blood Compensation Scheme."In the event that any potential claimant were to be able to make out a case that they had not received proper compensation, such claims could proceed efficiently and proportionately under court's ordinary powers of case management.""It is important that it should be understood this does not mean the court is preventing these potential claims from being progressed or is indicating any view upon the merits of the potential claims."In the event that any of the individual claimants wish to issue a claim, there is absolutely nothing to prevent them from doing so."Des Collins, a legal adviser to the claimants, said they were "surprised and disappointed" by Tuesday's judgment, which they intend to appeal."It cannot be right that the treatment of former pupils as guinea pigs by Treloar's in the 70s and 80s goes without sanction"Treloar's should not breathe a sigh of relief just yet since my clients remain determined to hold the school to account for the wrongs of the past."Reading a statement on the trust's behalf, Toby Riley-Smith KC said it was "so sorry" that many former pupils were among the affected. "It is so sorry that as a result, they and their loved ones have suffered so much, and for so long."It is so sorry that they have been victims of this tragedy, which Sir Brian Langstaff has described as the worst treatment disaster in the history of the NHS, a tragedy that has been compounded by the fact that it has taken so long for their plight to be recognised."After the judgment, a spokesperson for Treloar's said: "We firmly believe that the best route for our former students to receive timely and substantial recompense is via the government compensation scheme."We urge the Infected Blood Compensation Authority to pay the levels of compensation that have already been set as soon as possible."
You can follow BBC Hampshire & Isle of Wight on Facebook, X (Twitter), or Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ITV News
5 hours ago
- ITV News
'Concerning jump' in antibiotic resistant gonorrhoea
There has been a "concerning jump" in cases of gonorrhoea resistant to strong antibiotics, health officials have warned. New figures from the UK Health Security Agency (UKHSA) show there have been more cases of the sexually transmitted infection (STI) that are resistant to the antibiotic ceftriaxone so far in 2025 than the whole of last year. Overall, there was a 16% drop in gonorrhoea cases in 2024 in England, with 71,802 diagnoses, compared with 85,370 in 2023. However, ceftriaxone-resistant gonorrhoea cases are being detected more frequently - with 14 in the first five months of 2025 compared with 13 in the whole of the previous year. Six of the 14 cases this year have been "extensively drug-resistant", which means that they were resistant to ceftriaxone and then to second-line treatment options, according to the UKHSA. What is gonorrhoea? According to the NHS, Gonorrhoea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae. It is often symptomless, but symptoms can include unusual discharge from the genitals, pain during urination or sex, a sore throat, or redness in the eyes. Untreated gonorrhoea can cause serious complications which can lead to infertility in both men and women. If you think you might have gonorrhoea you can get tested for free through the NHS, either with a self-test kit or by going to a sexual health clinic. Gonorrhoea is treated with a single dose of antibiotics, which can be an injection or tablets. You would need to go back to your GP or clinic about a week later to check you no longer have gonorrhoea. Ceftriaxone is a strong antibiotic and the main treatment for gonorrhoea. Experts are therefore concerned when infections fail to respond to it. Most of these drug-resistant cases are linked with travel to or from the Asia-Pacific region, where the prevalence of ceftriaxone resistance is high. Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024. The overall figure for syphilis, including late-stage syphilis or complications from the infection, increased 5% from 12,456 in 2023 to 13,030 in 2024. Chlamydia fell 13%, from 194,143 diagnoses in 2023 to 168,889 in 2024, while people diagnosed for the first time with genital warts also dropped. Among women aged 15 to 24 who are recommended to be screened through the National Chlamydia Screening Programme (NCSP), there was a 10.7% decrease in the number of chlamydia tests carried out, from 673,102 to 601,295. Dr Hamish Mohammed, consultant epidemiologist at UKHSA, said: "Levels of STIs in this country remain a big threat to sexual wellbeing. "These infections can have a major impact on your health and that of any sexual partners - particularly if they are antibiotic resistant. "If you've had condomless sex with new or casual partners - either in the UK or overseas - get tested for STIs and HIV at least yearly, even if you don't have symptoms. Regular testing protects both you and those you're having sex with. "From August, eligible people will also be offered vaccination to reduce the risk of gonorrhoea and we expect to see the immunisation programme have an impact on diagnoses of this infection in coming years - please take up the vaccine if you are offered it."
Glasgow Times
5 hours ago
- Glasgow Times
Experts warn of ‘concerning jump' in antibiotic-resistant gonorrhoea
New figures from the UK Health Security Agency (UKHSA) show there have been more cases of the sexually transmitted infection (STI) gonorrhoea that are resistant to the antibiotic ceftriaxone so far in 2025 than the whole of last year. Overall, there was a 16% drop in gonorrhoea cases in 2024 in England, with 71,802 diagnoses, compared with 85,370 in 2023. However, ceftriaxone-resistant gonorrhoea cases are being detected more frequently – with 14 in the first five months of 2025 compared with 13 in the whole of the previous year. Six of the 14 cases this year have been 'extensively drug-resistant', which means that they were resistant to ceftriaxone and then to second-line treatment options, according to the UKHSA. Ceftriaxone is a strong antibiotic and the main treatment for gonorrhoea. Experts are therefore concerned when infections fail to respond to it. Most of these drug-resistant cases are linked with travel to or from the Asia-Pacific region, where the prevalence of ceftriaxone resistance is high. Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024. The overall figure for syphilis, including late-stage syphilis or complications from the infection, increased 5% from 12,456 in 2023 to 13,030 in 2024. Chlamydia fell 13%, from 194,143 diagnoses in 2023 to 168,889 in 2024, while people diagnosed for the first time with genital warts also dropped. Among women aged 15 to 24 who are recommended to be screened through the National Chlamydia Screening Programme (NCSP), there was a 10.7% decrease in the number of chlamydia tests carried out, from 673,102 to 601,295. Dr Hamish Mohammed, consultant epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual wellbeing. 'These infections can have a major impact on your health and that of any sexual partners – particularly if they are antibiotic resistant. 'If you've had condomless sex with new or casual partners – either in the UK or overseas – get tested for STIs and HIV at least yearly, even if you don't have symptoms. Regular testing protects both you and those you're having sex with. 'From August, eligible people will also be offered vaccination to reduce the risk of gonorrhoea and we expect to see the immunisation programme have an impact on diagnoses of this infection in coming years – please take up the vaccine if you are offered it.'
South Wales Guardian
5 hours ago
- South Wales Guardian
Experts warn of ‘concerning jump' in antibiotic-resistant gonorrhoea
New figures from the UK Health Security Agency (UKHSA) show there have been more cases of the sexually transmitted infection (STI) gonorrhoea that are resistant to the antibiotic ceftriaxone so far in 2025 than the whole of last year. Overall, there was a 16% drop in gonorrhoea cases in 2024 in England, with 71,802 diagnoses, compared with 85,370 in 2023. However, ceftriaxone-resistant gonorrhoea cases are being detected more frequently – with 14 in the first five months of 2025 compared with 13 in the whole of the previous year. Six of the 14 cases this year have been 'extensively drug-resistant', which means that they were resistant to ceftriaxone and then to second-line treatment options, according to the UKHSA. Ceftriaxone is a strong antibiotic and the main treatment for gonorrhoea. Experts are therefore concerned when infections fail to respond to it. Most of these drug-resistant cases are linked with travel to or from the Asia-Pacific region, where the prevalence of ceftriaxone resistance is high. Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024. The overall figure for syphilis, including late-stage syphilis or complications from the infection, increased 5% from 12,456 in 2023 to 13,030 in 2024. Chlamydia fell 13%, from 194,143 diagnoses in 2023 to 168,889 in 2024, while people diagnosed for the first time with genital warts also dropped. Among women aged 15 to 24 who are recommended to be screened through the National Chlamydia Screening Programme (NCSP), there was a 10.7% decrease in the number of chlamydia tests carried out, from 673,102 to 601,295. Dr Hamish Mohammed, consultant epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual wellbeing. 'These infections can have a major impact on your health and that of any sexual partners – particularly if they are antibiotic resistant. 'If you've had condomless sex with new or casual partners – either in the UK or overseas – get tested for STIs and HIV at least yearly, even if you don't have symptoms. Regular testing protects both you and those you're having sex with. 'From August, eligible people will also be offered vaccination to reduce the risk of gonorrhoea and we expect to see the immunisation programme have an impact on diagnoses of this infection in coming years – please take up the vaccine if you are offered it.'
